BSE Live
Mar 02, 16:01Prev. Close
4.43
Open Price
4.43
Bid Price (Qty.)
4.43 (83500)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Key Financial Ratios of Cresanto Global (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | -0.42 | -0.24 | -0.40 | -0.19 | -0.16 | |
| Diluted EPS (Rs.) | -0.42 | -0.24 | -0.40 | -0.19 | -0.16 | |
| Cash EPS (Rs.) | -0.41 | -0.23 | -0.39 | -0.18 | -0.15 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | -6.06 | -5.63 | -5.40 | -5.00 | -4.80 | |
| Book Value [InclRevalReserve]/Share (Rs.) | -6.06 | -5.63 | -5.40 | -5.00 | -4.80 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| PBDIT/Share (Rs.) | -0.14 | -0.23 | -0.39 | -0.18 | -0.15 | |
| PBIT/Share (Rs.) | -0.15 | -0.24 | -0.40 | -0.19 | -0.16 | |
| PBT/Share (Rs.) | -0.42 | -0.24 | -0.40 | -0.19 | -0.16 | |
| Net Profit/Share (Rs.) | -0.42 | -0.24 | -0.40 | -0.19 | -0.16 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| PBIT Margin (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| PBT Margin (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Profit Margin (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Return on Networth / Equity (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Return on Capital Employed (%) | 30.24 | -419.84 | -262.39 | -113.23 | 3.35 | |
| Return on Assets (%) | -578.52 | -67.38 | -109.88 | -33.31 | -27.35 | |
| Total Debt/Equity (X) | -0.92 | 0.00 | 0.00 | 0.00 | -1.05 | |
| Asset Turnover Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 0.13 | 0.04 | 0.06 | 0.52 | 0.04 | |
| Quick Ratio (X) | 0.13 | 0.04 | 0.06 | 0.52 | 0.04 | |
| Inventory Turnover Ratio (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 3.73 | 0.93 | 0.87 | 0.67 | 2.57 | |
| EV/Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EV/EBITDA (X) | -60.88 | -9.61 | -5.26 | -8.77 | -40.73 | |
| MarketCap/Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | -0.52 | -0.39 | -0.38 | -0.32 | -0.20 | |
| Price/Net Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Yield | -0.13 | -0.11 | -0.20 | -0.12 | -0.17 |
13.04.2026
13.04.2026
10.04.2026
09.04.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth